your clinician may monitor your pulse during treatment [16] [19] Gallbladder disease , including gallstones (cholelithiasis) and gallbladder inflammation (cholecystitis), is a recognised risk with GLP-1 receptor agonists and with rapid weight loss more broadly
Mounjaro is contraindicated in patients with a personal or family history of MTC or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
Receptor Binding : By binding to GLP-1 receptors in various tissues, semaglutide and tirzepatide influence multiple physiological processes related to weight management
A comprehensive treatment plan, including therapy, support groups, and lifestyle changes, is essential for long-term recovery
Other risks can come from contaminants, improper handling and storage as well as improper dosing instructions
But over the years, a question keeps coming up: what actually happens if a woman takes it